Potential link between the immune system and metabolism of nucleic acids

Current Opinion in Immunology

Volumn 20, Issue 5, 2008, Pages 524-529

  Ishii, Ken J ^a,b   Akira, Shizuo ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE A2A RECEPTOR; CD39 ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MYELOID DIFFERENTIATION FACTOR 88; NUCLEIC ACID; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE BINDING AND OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC RECEPTOR; RETINOIC ACID INDUCIBLE GENE I LIKE RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIC ACID DERIVATIVE;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; CELL DEATH; HOMEOSTASIS; HOST CELL; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; INNATE IMMUNITY; METABOLITE; NONHUMAN; NUCLEIC ACID METABOLISM; REVIEW;

ANIMALS; APOPTOSIS; DEAD-BOX RNA HELICASES; HUMANS; IMMUNE SYSTEM; NOD SIGNALING ADAPTOR PROTEINS; NUCLEIC ACIDS; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P2; TOLL-LIKE RECEPTORS;

EID: 50449205290     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2008.07.002     Document Type: Review

References (58)

1. Tesniere A., Panaretakis T., Kepp O., Apetoh L., Ghiringhelli F., Zitvogel L., and Kroemer G. Molecular characteristics of immunogenic cancer cell death. Cell Death Differ 15 (2008) 3-12
2. Peng Y., Martin D.A., Kenkel J., Zhang K., Ogden C.A., and Elkon K.B. Innate and adaptive immune response to apoptotic cells. J Autoimmun 29 (2007) 303-309
3. van der Most R.G., Currie A.J., Robinson B.W., and Lake R.A. Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all. Cell Death Differ 15 (2008) 13-20
4. Kono H., and Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 8 (2008) 279-289. This is an excellent review providing a comprehesive view about what could be 'danger signals' released by host dying cells.
5. Ishii K.J., Koyama S., Nakagawa A., Coban C., and Akira S. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3 (2008) 352-363
6. Ishii K.J., and Akira S. Innate immune recognition of nucleic acids: Beyond toll-like receptors. Int J Cancer 117 (2005) 517-523
7. Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 28 (2007) 465-472. This review covers the interesting area that connects inflammasome activation in innate immunity and the P2 receptor-mediated biological functions.
8. ••], these two reviews provide an insight into complex mechanisms that potentially link innate immune reponsese to nucleic acids and their metabolism.
9. Martinon F., Petrilli V., Mayor A., Tardivel A., and Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440 (2006) 237-241
10. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
11. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat Immunol 7 (2006) 131-137
12. Martinon F., and Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14 (2007) 10-22
13. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W.P., Weinrauch Y., Monack D.M., and Dixit V.M. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006) 228-232
14. Kariko K., and Weissman D. Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development. Curr Opin Drug Discov Dev 10 (2007) 523-532. This is an excellent review that covers a variety of nucleotide-modifications which may have a considerable impact on innate immunity to RNA.
15. Marshak-Rothstein A., and Rifkin I.R. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 25 (2007) 419-441
16. Christensen S.R., and Shlomchik M.J. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol 19 (2007) 11-23
17. Krug A. Nucleic acid recognition receptors in autoimmunity. Handb Exp Pharmacol (2008) 129-151
18. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314 (2006) 994-997
19. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., and Reis e Sousa. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 (2006) 997-1001
20. Nallagatla S.R., Hwang J., Toroney R., Zheng X., Cameron C.E., and Bevilacqua P.C. 5′-triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 318 (2007) 1455-1458
21. Takeuchi O., and Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 20 (2008) 17-22
22. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y.M., Gale Jr. M., Akira S., et al. Shared and unique functions of the DExD/H-Box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175 (2005) 2851-2858
23. Venkataraman T., Valdes M., Elsby R., Kakuta S., Caceres G., Saijo S., Iwakura Y., and Barber G.N. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 178 (2007) 6444-6455
24. Bowie A.G., and Fitzgerald K.A. RIG-I: tri-ing to discriminate between self and non-self RNA. Trends Immunol 28 (2007) 147-150
25. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., Hiiragi A., Dermody T.S., Fujita T., and Akira S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene I and melanoma differentiation-associated gene 5. J Exp Med 205 7 (2008) 1601-1610
26. Saito T., Owen D.M., Jiang F., Marcotrigiano J., and Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454 7203 (2008) 523-527
27. Malathi K., Dong B., Gale Jr. M., and Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448 (2007) 816-819
28. Nagata S. DNA degradation in development and programmed cell death. Annu Rev Immunol 23 (2005) 853-875
29. Ishii K.J., and Akira S. Innate immune recognition of, and regulation by. DNA Trends Immunol 27 (2006) 525-532
30. Wagner H., and Bauer S. All is not Toll: new pathways in DNA recognition. J Exp Med 203 (2006) 265-268
31. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 4 (2004) 249-258
32. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 5 (2006) 471-484
33. Christensen S.R., Shupe J., Nickerson K., Kashgarian M., Flavell R.A., and Shlomchik M.J. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25 (2006) 417-428
34. Wu X., and Peng S.L. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 54 (2006) 336-342
35. Lartigue A., Courville P., Auquit I., Francois A., Arnoult C., Tron F., Gilbert D., and Musette P. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J Immunol 177 (2006) 1349-1354
36. Roberts T.L., Sweet M.J., Hume D.A., and Stacey K.J. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides. J Immunol 174 (2005) 605-608
37. Yasuda K., Rutz M., Schlatter B., Metzger J., Luppa P.B., Schmitz F., Haas T., Heit A., Bauer S., and Wagner H. CpG motif-independent activation of TLR9 upon endosomal translocation of 'natural' phosphodiester DNA. Eur J Immunol 36 (2006) 431-436
38. Yasuda K., Yu P., Kirschning C.J., Schlatter B., Schmitz F., Heit A., Bauer S., Hochrein H., and Wagner H. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J Immunol 174 (2005) 6129-6136
39. Vallin H., Blomberg S., Alm G.V., Cederblad B., and Ronnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol 115 (1999) 196-202
40. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 (2002) 603-607
41. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., and Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 115 (2005) 407-417
42. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8 (2007) 487-496
43. Ivanov S., Dragoi A.M., Wang X., Dallacosta C., Louten J., Musco G., Sitia G., Yap G.S., Wan Y., Biron C.A., et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110 (2007) 1970-1981
44. Haas T., Metzger J., Schmitz F., Heit A., Muller T., Latz E., and Wagner H. The DNA sugar backbone 2′ deoxyribose determines toll-like receptor 9 activation. Immunity 28 (2008) 315-323. This is a very important paper demonstrated for the first time that TLR9 can be activated by sugar-backbone without bases of DNA.
45. Ishii K.J., Kawagoe T., Koyama S., Matsui K., Kumar H., Kawai T., Uematsu S., Takeuchi O., Takeshita F., Coban C., and Akira S. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451 (2008) 725-729
46. Kawane K., Ohtani M., Miwa K., Kizawa T., Kanbara Y., Yoshioka Y., Yoshikawa H., and Nagata S. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443 (2006) 998-1002
47. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448 (2007) 501-505
48. Kanneganti T.D., Body-Malapel M., Amer A., Park J.H., Whitfield J., Franchi L., Taraporewala Z.F., Miller D., Patton J.T., Inohara N., and Nunez G. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 281 (2006) 36560-36568
49. Kanneganti T.D., Ozoren N., Body-Malapel M., Amer A., Park J.H., Franchi L., Whitfield J., Barchet W., Colonna M., Vandenabeele P., et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440 (2006) 233-236
50. Muruve D.A., Petrilli V., Zaiss A.K., White L.R., Clark S.A., Ross P.J., Parks R.J., and Tschopp J. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452 (2008) 103-107
51. Leber J.H., Crimmins G.T., Raghavan S., Meyer-Morse N.P., Cox J.S., and Portnoy D.A. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog 4 (2008) e6
52. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
53. la Sala A., Sebastiani S., Ferrari D., Di Virgilio F., Idzko M., Norgauer J., and Girolomoni G. Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. Blood 99 (2002) 1715-1722
54. Sitkovsky M., and Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5 (2005) 712-721
55. ••].
56. Ohta A., and Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414 (2001) 916-920
57. Levy O., Coughlin M., Cronstein B.N., Roy R.M., Desai A., and Wessels M.R. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol 177 (2006) 1956-1966
58. Idzko M., Hammad H., van Nimwegen M., Kool M., Willart M.A., Muskens F., Hoogsteden H.C., Luttmann W., Ferrari D., Di Virgilio F., et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13 (2007) 913-919